FDA Approval Activities for this Drug
Inspra (eplerenone) Tablets, 25, 50, & 100 mg, G.D. Searle NDA 21-437 | Inspra (eplerenone) Tablets, Pfizer, Patient Population Altered | Inspra (eplerenone) Tablets, Pfizer Global Pharmaceuticals, Labeling Revision | Eplerenone Tablets, Apotex Corp., Approval | Eplerenone Tablets, Sandoz, Inc., Approval